Cargando…
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
The current treatment for drug-resistant tuberculosis (TB) is long, complex, and associated with severe and life-threatening side effects and poor outcomes. For the first time in nearly 50 years, there have been two new drugs registered for use in multidrug-resistant TB (MDR-TB). Bedaquiline, a diar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634826/ https://www.ncbi.nlm.nih.gov/pubmed/26586956 http://dx.doi.org/10.2147/IDR.S68351 |